Pacira Biosciences Inc (PCRX)

06:30 AM

Why Pacira BioSciences Inc. (82P) stock could outperform next yearJuly 2025 Volume & Community Consensus Picks - newser.com

06:30 AM

06:14 AM

Pacira BioSciences Inc. recovery potential after sell off2025 Market Overview & Community Consensus Stock Picks - newser.com

06:14 AM

05:24 AM

How to integrate Pacira BioSciences Inc. into portfolio analysis toolsTrade Risk Report & AI Based Buy and Sell Signals - newser.com

05:24 AM

05:13 AM

Building trade automation scripts for Pacira BioSciences Inc.2025 Momentum Check & Fast Moving Stock Watchlists - newser.com

05:13 AM

04:34 AM

Can a trend reversal in Pacira BioSciences Inc. lead to recoveryJuly 2025 Rallies & Stepwise Trade Signal Implementation - newser.com

04:34 AM

02:12 AM

Real time social sentiment graph for Pacira BioSciences Inc.2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - newser.com

02:12 AM

01:31 AM

Is Pacira BioSciences Inc. stock poised for growthBuy Signal & Free Accurate Trade Setup Notifications - newser.com

01:31 AM

01:07 AM

Chart based analysis of Pacira BioSciences Inc. trendsJuly 2025 Update & Fast Exit Strategy with Risk Control - newser.com

01:07 AM

12:40 PM

Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025 - markets.businessinsider.com

12:40 PM

Oct 30, 2025

Pacira BioSciences Inc. stock retracement – recovery analysis2025 Growth vs Value & High Accuracy Buy Signal Tips - newser.com

Oct 30, 2025

Oct 30, 2025

Pacira Biosciences, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Trends - Markets Mojo

Oct 30, 2025

Oct 30, 2025

Pacira BioSciences (PCRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

Oct 30, 2025

Oct 30, 2025

Pacira BioSciences (Nasdaq: PCRX) sets Nov. 6 third-quarter results; call at 4:30 p.m. ET - Stock Titan

Oct 30, 2025

Oct 30, 2025

Will Pacira BioSciences Inc. stock keep outperforming rivalsMarket Sentiment Report & Technical Analysis for Trade Confirmation - newser.com

Oct 30, 2025

Oct 29, 2025

What is the fair value estimate for Pacira BioSciences Inc. (82P) stock in 2025Market Trend Review & Weekly Momentum Stock Picks - newser.com

Oct 29, 2025

Oct 29, 2025

Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee - markets.businessinsider.com

Oct 29, 2025

Oct 28, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Oct 28, 2025

Oct 28, 2025

Pacira BioSciences, Inc. Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-To-Severe Osteoarthritis of the Knee - MarketScreener

Oct 28, 2025

Oct 28, 2025

Pacira BioSciences (PCRX) Reports Promising Three-Year Findings for PCRX-201 - GuruFocus

Oct 28, 2025

Oct 28, 2025

Is Pacira BioSciences Inc. stock a buy on dipsForecast Cut & Smart Investment Allocation Insights - Fundação Cultural do Pará

Oct 28, 2025

Oct 27, 2025

Pacira Biosciences Increceives Paragraph IV notice from Qilu Pharmaceutical - MarketScreener

Oct 27, 2025

Oct 27, 2025

Pacira BioSciences receives patent challenge for EXPAREL from Chinese firm - Investing.com

Oct 27, 2025

Oct 27, 2025

Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL® - The Manila Times

Oct 27, 2025

Oct 27, 2025

Pacira BioSciences Receives PIV Notice from Qilu Pharmaceutical Regarding Generic EXPAREL Patent Claims - Quiver Quantitative

Oct 27, 2025

Oct 27, 2025

Pacira BioSciences (NASDAQ: PCRX) notes PIV ANDA for EXPAREL; 45 days to file suit - Stock Titan

Oct 27, 2025

Oct 27, 2025

How Pacira BioSciences Inc. stock trades before earnings2025 Risk Factors & Low Drawdown Momentum Ideas - newser.com

Oct 27, 2025